Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic L

Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics, Cardiac Bionics)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Artificial Vital Organs are man-made devices that are created to work like original diseases organ or to restore a specific function of that organ. These devices are implanted at the site of the diseased organ in the patient. Medical bionics is the study of application of mechanics and electronics for the replacement of a limb or other part of a functional organ that is mechanically powered. Artificial organs can be an artificial heart, artificial kidney, artificial pancreas and others. An artificial organ consists of different parts that mimic functions of the original organ. For instance, artificial pancreas systems comprise of devices that are already used in diabetes management such as Continuous glucose monitoring (CGM) device, insulin pump, blood glucose device (BGD), and digital control device with control algorithm. Artificial pancreas systems are compatible with existing pumps and CGMs and its control functions can be integrated into a regular smartphone.

Restraints of the Global Artificial Vital Organs and Medical Bionics Market
Major factors hampering the growth of the Artificial Vital Organs and Medical Bionics market during the forecast period constitutes of criticism associated with artificial organ transplant, and high costs.
Key features of the study:
This report provides in-depth analysis of the global Artificial Vital Organs and Medical Bionics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Artificial Vital Organs and Medical Bionics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Artificial Vital Organs and Medical Bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Artificial Vital Organs and Medical Bionics Market, By Type:
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
Global Artificial Vital Organs and Medical Bionics Market, By Geography:
North America
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country:
U.S.
Canada
Europe
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Artificial Vital Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Medical Bionics
Cochlear Implants
Vision Bionics
Exoskeletons
Bionic Limbs
Brain Bionics
Cardiac Bionics
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
SynCardia Systems, LLC*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
BiVACOR
CARMAT
Cleveland Heart
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Cyberonics, Inc.
Edwards Lifesciences Corporation
Other Major Players
“*” marked represents similar segmentation in other categories in the respective section.